Browse diseases

…Background Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwi…

…is a progressive condition that may lead to liver cirrhosis and hepatocellular carcinoma. It is strongly associated with cardiometabolic diseases such a…

…ne checkpoint inhibitors (ICIs) demonstrate limited efficacy in hepatocellular carcinoma (HCC), largely attributable to a profoundly immunosuppressive t…

… to ArLD (AAPC 3.28), liver cancer due to HepB (AAPC 3.17), and liver cancer due to HepC (AAPC 3.14). In regard to the ASDR, a statistically…

…stigation—confirmed in multiple cohorts—show that patients with hepatocellular carcinoma, who favorably responded to anti-programmed cell death protein …

…ase radiomic-based models can predict recurrence after curative HCC ablation. Pretreatment MRI can identify patients at high-risk o…

…Background and Aims Liver disease is a growing public health concern worldwide with increasing mo…

…onclusion(s) ELA 120mg has been well tolerated in patients with PSC in the ELMWOOD OLE. All groups show reductions in biochemical m…

…tations. This study aims to evaluate the performance of current HCC pathways in the UK.Methods A multi-centre retrospective study w…

…Introduction Budd-Chiari syndrome (BCS) is a vascular liver disorder that can lead to lethal port…

… occupational and socioeconomic risk factors may play a role in HCC development among cirrhotic patients after sustained viral clea…

…atment for decompensated liver disease, acute liver failure and hepatocellular carcinoma. Graft complications and long-term immunosuppression are associ…